When the company reported VK2735's phase 2 results last year, the stock jumped 121% in one trading session. Viking gave back ...

Some you might hold only temporarily, while others you own for decades. David Jagielski (Eli Lilly): A forever stock you can ...

Let's look at five pharma and drug companies, MRK PFE, LLY, AMGN and BMY, which are scheduled to release their fourth-quarter ...

The biotech sector witnessed a ... IMCR currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here. Loss per share estimates for 2025 ...

And you won't need a boatload of cash to invest in a few of them. Here are three no-brainer biotech stocks to buy with $200 right now. Biotech stocks usually appeal more to aggressive growth ...

Here's why I think Vertex Pharmaceuticals (NASDAQ: VRTX) is the ultimate biotech stock to buy with $500 right now. Many biotechnology companies don't have approved products on the market ...

Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.

Precision medicine is revolutionizing healthcare, and these genomic stocks are leading the way. Therefore, as this sector ...

Members of The Biotech Forum get exclusive ideas and ... and Piper Sandler have all reiterated their Buy ratings on the stocks. Albeit seven of these ratings contain downward price target revisions.

BMO Capital analyst Kostas Biliouris has maintained their bullish stance on LEGN stock, giving a Buy rating yesterday.Invest with Confidence: ...

H.C. Wainwright analyst Patrick Trucchio reiterated a Buy rating on Vir Biotechnology (VIR – Research Report) today and set a price target of $110.00. Discover outperforming stocks and invest ...